As at January 28, 2022Show prices
SaskWorks Diversified (Class A - Series A) 23.0821
SaskWorks Diversified (Class A - Series B) 23.1965
SaskWorks Diversified (Class A - Series F) 26.3960
SaskWorks Resources (Class R - Series A) 16.0163
SaskWorks Resources (Class R - Series B) 16.1450
SaskWorks Resources (Class R - Series F) 16.4979
CanniMed Therapeutics Inc. (CMED.TO) (“CanniMed” or the “Company”) announced today that its directors have approved the commencement of a capital project to increase its current cannabinoid oils processing capacity by constructing a new facility on the Company’s Saskatchewan campus…
CanniMed Therapeutics Inc. (TSX: CMED) (“CMED” or the “Company”), announces, in accordance with the Toronto Stock Exchange requirements, the voting results from its Annual General Meeting held Wednesday, April 19, 2017 in Saskatoon, Saskatchewan…
Please select the option that best describes you:
